Garland Capital Management Inc has filed its 13F form on July 30, 2024 for Q2 2024 where it was disclosed a total value porftolio of $141 Million distributed in 32 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Jpmorgan Chase & CO with a value of $8.77M, Abb Vie Inc. with a value of $7.64M, Merck & Co., Inc. with a value of $7.56M, Procter & Gamble CO with a value of $6.85M, and Travelers Companies, Inc. with a value of $6.1M.

Examining the 13F form we can see an decrease of $9.48M in the current position value, from $151M to 141M.

Below you can find more details about Garland Capital Management Inc portfolio as well as his latest detailed transactions.

Portfolio value $141 Million
Healthcare: $36.4 Million
Financial Services: $29.9 Million
Technology: $14.2 Million
Industrials: $13.7 Million
Real Estate: $13.6 Million
Consumer Defensive: $12.3 Million
Energy: $8.95 Million
Basic Materials: $4.1 Million
Other: $8.3 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 32
  • Current Value $141 Million
  • Prior Value $151 Million
  • Filing
  • Period Q2 2024
  • Filing Date July 30, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 1 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 18 stocks
Track This Portfolio

Track Garland Capital Management Inc Portfolio

Follow Garland Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garland Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garland Capital Management Inc with notifications on news.